October 14, 2019 Clinical Research/Diagn. Licensing, IP, and Legal

BD and Check-Points Receive FDA Clearance for Molecular Screening Test to Detect Antibiotic-Resistant Bacteria

Oct 29, 2019 FRANKLIN LAKES, N.J., and WAGENINGEN, THE NETHERLANDS, October 29, 2019 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, along with Check-Points Health B.V., announced today that FDA 510(k) clearance was obtained for a molecular screening test for antibiotic-resistant carbapenemase-producing organisms (CPOs) on the fully-automated BD MAX™ System. The BD MAX™ Check-Points... Read more

April 16, 2019 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 M&A, Partnerships Mass Spectrometry

Bruker and the Translational Metabolic Laboratory at Radboud University Medical Center Announce the Establishment of a Joint Center of Excellence for Translational Omics

Nijmegen, Netherlands, April 16, 2019 – At the opening event of the Netherlands X-omics Initiative, Bruker and the Translation Metabolic Laboratory (TML) at Radboud University Medical Center (UMC) today jointly announce the establishment of a Center of Excellence (CoE) for Translational Omics. Under the leadership of Professor Alain van Gool, the joint CoE will focus on... Read more